跳至主要内容
临床试验/TCTR20201223001
TCTR20201223001招募中2 期

A comparison of combined EUS-guided radiofrequency ablation using EUSRA RF electrode and chemotherapy vs. chemotherapy alone in locally advanced pancreatic cancer: a phase II/III randomized controlled trial

Scholarship0 个研究点目标入组 26 人开始时间: 2020年12月23日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • 1. Histology or cytology confirmed locally advanced unresectable pancreatic ductal adenocarcinoma patients (AJCC 8th stage III)
  • 2. ECOG status below or equal to 2
  • 3. Age 18 - 85 years old and willing to participate in a clinical trial

排除标准

  • 1. Patients with technical restriction in performing EUS-guided radiofrequency ablation
  • 2. Pregnant women
  • 3. Prior received standard treatment for pancreatic cancer
  • 4. Patients with uncorrectable coagulopathy (INR > 1.5 times upper normal limit, aPTT > 2 times upper normal limit or platelet < 50,000)

研究者

发起方
Scholarship

相似试验